Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma
2022 · Journal of Nanobiotechnology · 61 citations
https://doi.org/10.1186/s12951-022-01397-7
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
165
Citations
5
h-index
4
i10-index
Lingyu Qian is an academic researcher from Nanjing Drum Tower Hospital. The author has contributed to research in topics: HIV Research and Treatment & Cancer Immunotherapy and Biomarkers & HIV/AIDS drug development and treatment. The author has an h-index of 5, co-authored 6 publications.
Click to start Chat